14-3-3 mitigates alpha-synuclein aggregation and toxicity in the in vivo preformed fibril model

被引:20
作者
Underwood, Rachel [1 ,3 ]
Gannon, Mary [1 ]
Pathak, Aneesh [1 ]
Kapa, Navya [1 ]
Chandra, Sidhanth [1 ,4 ]
Klop, Alyssa [1 ]
Yacoubian, Talene A. [1 ,2 ]
机构
[1] Univ Alabama Birmingham, Dept Neurol, Ctr Neurodegenerat & Expt Therapeut, Birmingham, AL 35294 USA
[2] Civitan Int Res Ctr, Room 510A,1719 Sixth Ave South, Birmingham, AL 35294 USA
[3] Univ Penn, Ctr Neurodegenerat Dis Res, Perelman Sch Med, Maloney Bldg,3rd Floor,3600 Spruce St, Philadelphia, PA 19104 USA
[4] Northwestern Univ, Med Scientist Training Program, Feinberg Sch Med, Chicago, IL 60611 USA
关键词
14-3-3s; Alpha-synuclein; Parkinson's disease; Dementia with Lewy Bodies; Substantia nigra; Amygdala; Cortex; Mouse;
D O I
10.1186/s40478-020-01110-5
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Alpha-synuclein (alpha syn) is the key component of proteinaceous aggregates termed Lewy Bodies that pathologically define a group of disorders known as synucleinopathies, including Parkinson's Disease (PD) and Dementia with Lewy Bodies. alpha Syn is hypothesized to misfold and spread throughout the brain in a prion-like fashion. Transmission of alpha syn necessitates the release of misfolded alpha syn from one cell and the uptake of that alpha syn by another, in which it can template the misfolding of endogenous alpha syn upon cell internalization. 14-3-3 proteins are a family of highly expressed brain proteins that are neuroprotective in multiple PD models. We have previously shown that 14-3-3 theta acts as a chaperone to reduce alpha syn aggregation, cell-to-cell transmission, and neurotoxicity in the in vitro pre-formed fibril (PFF) model. In this study, we expanded our studies to test the impact of 14-3-3s on alpha syn toxicity in the in vivo alpha syn PFF model. We used both transgenic expression models and adenovirus associated virus (AAV)-mediated expression to examine whether 14-3-3 manipulation impacts behavioral deficits, alpha syn aggregation, and neuronal counts in the PFF model. 14-3-3 theta transgene overexpression in cortical and amygdala regions rescued social dominance deficits induced by PFFs at 6 months post injection, whereas 14-3-3 inhibition by transgene expression of the competitive 14-3-3 peptide inhibitor difopein in the cortex and amygdala accelerated social dominance deficits. The behavioral rescue by 14-3-3 theta overexpression was associated with delayed alpha syn aggregation induced by PFFs in these brain regions. Conversely, 14-3-3 inhibition by difopein in the cortex and amygdala accelerated alpha syn aggregation and reduction in NECAB1-positive neuron counts induced by PFFs. 14-3-3 theta overexpression by AAV in the substantia nigra (SN) also delayed alpha syn aggregation in the SN and partially rescued PFF-induced reduction in tyrosine hydroxylase (TH)-positive dopaminergic cells in the SN. 14-3-3 inhibition in the SN accelerated nigral alpha syn aggregation and enhanced PFF-induced reduction in TH-positive dopaminergic cells. These data indicate a neuroprotective role for 14-3-3 theta against alpha syn toxicity in vivo.
引用
收藏
页数:16
相关论文
共 56 条
  • [11] 14-3-3ζ is an effector of tau protein phosphorylation
    Hashiguchi, M
    Sobue, K
    Paudel, HK
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 2000, 275 (33) : 25247 - 25254
  • [12] Structurally distinct α-synuclein fibrils induce robust parkinsonian pathology
    Hayakawa, Hideki
    Nakatani, Rie
    Ikenaka, Kensuke
    Aguirre, Cesar
    Choong, Chi-Jing
    Tsuda, Hiroshi
    Nagano, Seiichi
    Koike, Masato
    Ikeuchi, Takeshi
    Hasegawa, Masato
    Papa, Stella M.
    Nagai, Yoshitaka
    Mochizuki, Hideki
    Baba, Kousuke
    [J]. MOVEMENT DISORDERS, 2020, 35 (02) : 256 - 267
  • [13] SLITRK1 Binds 14-3-3 and Regulates Neurite Outgrowth in a Phosphorylation-Dependent Manner
    Kajiwara, Yuji
    Buxbaum, Joseph D.
    Grice, Dorothy E.
    [J]. BIOLOGICAL PSYCHIATRY, 2009, 66 (10) : 918 - 925
  • [14] 14-3-3 proteins in Lewy bodies in Parkinson disease and diffuse Lewy body disease brains
    Kawamoto, Y
    Akiguchi, I
    Nakamura, S
    Honjyo, Y
    Shibasaki, H
    Budka, H
    [J]. JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY, 2002, 61 (03) : 245 - 253
  • [15] Noninvasive in vivo assessment of muscle impairment in the mdx mouse model - A comparison of two common wire hanging methods with two different results
    Klein, Silvan M.
    Vykoukal, Jody
    Lechler, Philipp
    Zeitler, Katharina
    Gehmert, Sebastian
    Schreml, Stephan
    Alt, Eckhard
    Bogdahn, Ulrich
    Prantl, Lukas
    [J]. JOURNAL OF NEUROSCIENCE METHODS, 2012, 203 (02) : 292 - 297
  • [16] 14-3-3 Proteins regulate mutant LRRK2 kinase activity and neurite shortening
    Lavalley, Nicholas J.
    Slone, Sunny R.
    Ding, Huiping
    West, Andrew B.
    Yacoubian, Talene A.
    [J]. HUMAN MOLECULAR GENETICS, 2016, 25 (01) : 109 - 122
  • [17] Neurofibrillary tangles of Alzheimer's disease brains contain 14-3-3 proteins
    Layfield, R
    Fergusson, J
    Aitken, A
    Lowe, J
    Landon, M
    Mayer, RJ
    [J]. NEUROSCIENCE LETTERS, 1996, 209 (01) : 57 - 60
  • [18] Pathological α-Synuclein Transmission Initiates Parkinson-like Neurodegeneration in Nontransgenic Mice
    Luk, Kelvin C.
    Kehm, Victoria
    Carroll, Jenna
    Zhang, Bin
    O'Brien, Patrick
    Trojanowski, John Q.
    Lee, Virginia M. -Y.
    [J]. SCIENCE, 2012, 338 (6109) : 949 - 953
  • [19] The process of Lewy body formation, rather than simply α-synuclein fibrillization, is one of the major drivers of neurodegeneration
    Mahul-Mellier, Anne-Laure
    Burtscher, Johannes
    Maharjan, Niran
    Weerens, Laura
    Croisier, Marie
    Kuttler, Fabien
    Leleu, Marion
    Knott, Graham W.
    Lashuel, Hilal A.
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2020, 117 (09) : 4971 - 4982
  • [20] Dysregulation of 14-3-3 proteins in neurodegenerative diseases with Lewy body or Alzheimer pathology
    McFerrin, Michael B.
    Chi, Xiaofei
    Cutter, Gary
    Yacoubian, Talene A.
    [J]. ANNALS OF CLINICAL AND TRANSLATIONAL NEUROLOGY, 2017, 4 (07): : 466 - 477